Pfizer (PFE) CFO Dave Denton joins Oliver Renick to discuss the company's outlook and 2Q earnings. As @pfizer continues to rally from post-pandemic lows, Denton details the company's pipeline which includes a weight-loss product in the GLP-1 market.